MatthewStephenNingMDMPH
Radiation Oncology • Houston, TXThoracic Cancer
Assistant Professor / Director of Clinical Value
Dr. Ning is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 2016 - 2020
University of Texas Health Science Center (UT Health)MPH, Healthcare Management, Delta Omega Honorary Society, 2018 - 2019
MedStar Health/Georgetown-Washington Hospital CenterInternship, Internal Medicine, 2015 - 2016
Vanderbilt University School of MedicineClass of 2015, MD- Virginia Polytechnic Institute and State University (Virginia Tech)BS, Biochemistry, Outstanding Graduating Senior of the College of Science, 2007 - 2011
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2022 - 2026
GA State Medical License 2022 - 2026
AL State Medical License 2023 - 2025
LA State Medical License 2022 - 2025
MS State Medical License 2022 - 2025
OK State Medical License 2022 - 2025- American Board of Radiology Radiation Oncology
- Join now to see all
Publications & Presentations
PubMed
- Recurrent Poorly Differentiated Thyroid Cancer Successfully Treated With Radiation and Immunotherapy.Sarah Hamidi, Matthew S Ning, Jack Phan, Mark E Zafereo, Maria K Gule-Monroe
JCEM Case Reports. 2025-02-01 - Performance Comparison of 10 State-of-the-Art Machine Learning Algorithms for Outcome Prediction Modeling of Radiation-Induced Toxicity.Ramon M Salazar, Saurabh S Nair, Alexandra O Leone, Ting Xu, Raymond P Mumme
Advances in Radiation Oncology. 2025-02-01 - Definitive Radiotherapy for Oligometastatic and Oligoprogressive Thyroid Cancer: A Potential Strategy for Systemic Therapy Deferral.Stephanie O Dudzinski, Maria E Cabanillas, Sarah Hamidi, Vicente R Marczyk, Naifa L Busaidy
Journal of the National Comprehensive Cancer Network. 2024-12-11
Authored Content
- Cost Analysis of PET/CT vs. CT as Surveillance for Stage III Non-Small Cell Lung Cancer After Definitive Radiation TherapyMarch 2018
Press Mentions
MD Anderson Research Highlights for December 18, 2024December 18th, 2024
Low-Dose Radiation Effective With/Without Concurrent Chemotherapy in R/R Mantle Cell LymphomaSeptember 5th, 2019
External Links
- MD Anderson Faculty Profilehttps://faculty.mdanderson.org/profiles/matthew_ning.html
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
